tiprankstipranks
Recordati Industria Chimica e Farmaceutica SPA (GB:0KBS)
LSE:0KBS
UK Market
0KBS
Recordati Industria Chimica e Farmaceutica SPA
RESEARCH TOOLSreports

Recordati Industria Chimica e Farmaceutica SPA (0KBS) Ratios

0 Followers

Recordati Industria Chimica e Farmaceutica SPA Ratios

GB:0KBS's free cash flow for Q4 2025 was €0.71. For the 2025 fiscal year, GB:0KBS's free cash flow was decreased by € and operating cash flow was €0.27. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.59 1.59 1.61 1.20 1.28
Quick Ratio
 1.08 1.08 1.06 0.79 0.82
Cash Ratio
 0.41 0.41 0.35 0.22 0.31
Solvency Ratio
 0.20 0.20 0.18 0.21 0.18
Operating Cash Flow Ratio
 0.57 0.57 0.61 0.48 0.50
Short-Term Operating Cash Flow Coverage
 25.03 25.03 1.87 4.86 1.21
Net Current Asset Value
€ -1.65B€ -1.65B€ -1.77B€ -1.32B€ -1.27B
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 0.48 0.35 0.43
Debt-to-Equity Ratio
 0.01 0.01 1.33 0.87 1.11
Debt-to-Capital Ratio
 0.01 0.01 0.57 0.46 0.53
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.53 0.44 0.46
Financial Leverage Ratio
 2.74 2.74 2.74 2.50 2.59
Debt Service Coverage Ratio
 6.08 6.09 1.72 3.48 1.13
Interest Coverage Ratio
 7.24 7.25 7.83 7.49 13.54
Debt to Market Cap
 <0.01 <0.01 0.23 0.14 0.21
Interest Debt Per Share
 0.60 0.60 12.46 7.48 8.51
Net Debt to EBITDA
 -0.46 -0.46 2.73 1.75 2.56
Profitability Margins
Gross Profit Margin
68.27%68.27%68.34%68.32%69.42%
EBIT Margin
25.99%25.99%26.83%27.16%23.40%
EBITDA Margin
33.88%33.88%33.97%34.01%30.18%
Operating Profit Margin
27.49%27.49%27.29%26.80%23.60%
Pretax Profit Margin
22.20%22.20%23.37%23.58%21.66%
Net Profit Margin
16.94%16.94%17.79%18.69%16.85%
Continuous Operations Profit Margin
16.94%16.94%17.79%18.69%16.85%
Net Income Per EBT
76.32%76.32%76.12%79.26%77.80%
EBT Per EBIT
80.76%80.76%85.64%88.00%91.79%
Return on Assets (ROA)
8.45%8.45%8.11%9.25%7.81%
Return on Equity (ROE)
23.06%23.11%22.19%23.08%20.20%
Return on Capital Employed (ROCE)
17.14%17.14%15.19%17.41%14.22%
Return on Invested Capital (ROIC)
13.01%13.01%10.76%13.34%9.81%
Return on Tangible Assets
21.50%21.50%22.83%26.09%21.38%
Earnings Yield
4.31%4.45%3.99%3.86%3.92%
Efficiency Ratios
Receivables Turnover
 4.44 4.44 4.53 4.68 4.95
Payables Turnover
 2.41 2.41 2.50 2.50 2.52
Inventory Turnover
 1.54 1.54 1.46 1.63 1.34
Fixed Asset Turnover
 11.78 11.78 11.33 11.66 11.64
Asset Turnover
 0.50 0.50 0.46 0.49 0.46
Working Capital Turnover Ratio
 4.04 4.41 6.15 9.02 7.63
Cash Conversion Cycle
 167.77 167.77 183.83 155.97 202.20
Days of Sales Outstanding
 82.25 82.25 80.55 78.04 73.80
Days of Inventory Outstanding
 237.18 237.18 249.37 223.98 273.12
Days of Payables Outstanding
 151.67 151.67 146.09 146.05 144.72
Operating Cycle
 319.44 319.44 329.92 302.02 346.92
Cash Flow Ratios
Operating Cash Flow Per Share
 2.90 2.90 2.76 2.36 2.25
Free Cash Flow Per Share
 2.48 2.49 2.59 0.50 1.78
CapEx Per Share
 0.41 0.41 0.18 1.86 0.47
Free Cash Flow to Operating Cash Flow
 0.86 0.86 0.94 0.21 0.79
Dividend Paid and CapEx Coverage Ratio
 1.69 1.69 1.96 0.77 1.41
Capital Expenditure Coverage Ratio
 7.01 7.01 15.55 1.27 4.79
Operating Cash Flow Coverage Ratio
 25.03 25.03 0.23 0.33 0.27
Operating Cash Flow to Sales Ratio
 0.23 0.23 0.24 0.23 0.25
Free Cash Flow Yield
5.00%5.13%5.13%1.01%4.59%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 23.22 22.48 25.06 25.89 25.51
Price-to-Sales (P/S) Ratio
 3.91 3.81 4.46 4.84 4.30
Price-to-Book (P/B) Ratio
 5.36 5.20 5.56 5.97 5.15
Price-to-Free Cash Flow (P/FCF) Ratio
 19.99 19.49 19.51 98.73 21.80
Price-to-Operating Cash Flow Ratio
 17.25 16.71 18.32 20.76 17.25
Price-to-Earnings Growth (PEG) Ratio
 -1.20 3.24 3.64 1.06 -1.36
Price-to-Fair Value
 5.36 5.20 5.56 5.97 5.15
Enterprise Value Multiple
 11.07 10.79 15.85 15.98 16.80
Enterprise Value
 9.82B 9.57B 12.61B 11.32B 9.40B
EV to EBITDA
 11.07 10.79 15.85 15.98 16.80
EV to Sales
 3.75 3.65 5.38 5.44 5.07
EV to Free Cash Flow
 19.19 18.70 23.56 110.90 25.72
EV to Operating Cash Flow
 16.46 16.03 22.12 23.32 20.36
Tangible Book Value Per Share
 -6.16 -6.18 -6.95 -5.01 -4.83
Shareholders’ Equity Per Share
 9.32 9.34 9.10 8.20 7.52
Tax and Other Ratios
Effective Tax Rate
 0.24 0.24 0.24 0.21 0.22
Revenue Per Share
 12.71 12.74 11.35 10.13 9.01
Net Income Per Share
 2.15 2.16 2.02 1.89 1.52
Tax Burden
 0.76 0.76 0.76 0.79 0.78
Interest Burden
 0.85 0.85 0.87 0.87 0.93
Research & Development to Revenue
 0.13 0.13 0.12 0.12 0.12
SG&A to Revenue
 0.28 0.28 0.28 0.06 0.06
Stock-Based Compensation to Revenue
 <0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
 1.35 1.35 1.37 1.25 1.48
Currency in EUR